Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tvardi Therapeutics (TVRD) Shares Outstanding (2016 - 2025)

Tvardi Therapeutics' Shares Outstanding history spans 13 years, with the latest figure at $9.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 264.36% to $9.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.4 million, a 264.36% increase, with the full-year FY2025 number at $9.4 million, up 515.68% from a year prior.
  • Shares Outstanding hit $9.4 million in Q4 2025 for Tvardi Therapeutics, roughly flat from $9.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for TVRD hit a ceiling of $54.8 million in Q3 2024 and a floor of -$16.6 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $25.6 million across 5 years, with a median of $9.4 million in 2025.
  • Biggest five-year swings in Shares Outstanding: surged 166860.54% in 2021 and later plummeted 97.19% in 2024.
  • Tracing TVRD's Shares Outstanding over 5 years: stood at $4.5 million in 2021, then grew by 0.59% to $4.5 million in 2022, then tumbled by 42.76% to $2.6 million in 2023, then rose by 0.33% to $2.6 million in 2024, then surged by 264.36% to $9.4 million in 2025.
  • Business Quant data shows Shares Outstanding for TVRD at $9.4 million in Q4 2025, $9.4 million in Q3 2025, and $9.4 million in Q2 2025.